Related Experiment Video
Updated: Aug 5, 2026

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
Published on: September 10, 2018
[When treatment has anti-doping implications: therapeutic use exemptions in primary care]
M Sarmiento-Cruz1, J I Ramírez-Manent2
1Medicina de la Educación Física y el Deporte, Centro de Salud Son Cladera, IBSALUT, Ex Departamento de Control de Dopaje, Agencia Estatal Comisión Española para la Lucha Antidopaje en el Deporte (CELAD), Palma, España; Grupo de Trabajo de Actividad Física y Salud, Semfyc, Barcelona, España.
None:
Therapeutic use exemptions (TUEs) allow athletes to use prohibited substances or methods when there is a justified medical indication and the criteria established by anti-doping regulations are fulfilled. Although TUEs are commonly associated with professional sport, family physicians may care for federated athletes or individuals subject to anti-doping testing at different levels of competition. In primary care, commonly prescribed treatments such as systemic glucocorticoids, β2-agonists, beta-blockers or diuretics may have regulatory implications if the substance used, dosage, route of administration, timing in relation to competition and clinical context are not adequately considered. In addition, substances of abuse, cannabinoids, and some cold remedies and decongestants may lead to unexpected adverse analytical findings. This article provides practical recommendations aimed at identifying patients at risk, using official consultation tools, adequately justifying medical indications and safely managing common situations related to TUEs in daily clinical practice. .
Related Concept Videos
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring: Overview and Classification
Bioequivalence of Drugs: Drugs with Multiple Indications
Therapeutic Drug Monitoring: Drug Analysis Methods
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

